Accolade (ACCD) Stock Price & Analysis

ACCD price $7.02 0.00 0.00%

Ticker
ACCD
Price
$7.02
Change
0.00 0.00%
Market cap ?
$575.59M
P/E ?
-5.28
Forward P/E ?
19.50
Dividend yield ?
0.00%
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Stocklytics score
57
Value
55
Quality
31
Growth
86

Stocklytics score rationale: value 55, quality 31, growth 86.

Financials

2018201920202021202220232024
$76.83M$94.81M$132.51M$170.36M$310.02M$363.14M$414.29M

Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.

Fair value

ACCD fair value $10.47. Price $7.02. Price is 33% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an industry P/E: the average of the DCF value and an earnings value from next-twelve-months EPS times the industry median P/E. How we calculate it →

Compare ACCD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2025-04-24-0.100.05—145.50M
2025-01-09-1.50-0.32105.06M105.99M
2024-10-08-0.30-0.45106.36M105.01M
2024-06-27-0.35-0.48110.47M105.22M
2024-04-25-0.10-0.11124.83M123.91M
2024-01-08-0.28-0.4699.37M123.92M
2023-10-04-0.43-0.5696.86M94.09M
2023-06-29-0.52-0.6493.23M94.11M
2023-04-27-0.42-0.4399.03M99.44M
2023-01-09-0.56-0.6190.95M87.53M
2022-10-06-0.66-0.7187.64M82.86M
2022-06-30-4.92-0.7385.53M81.98M
2022-04-28-0.51-0.3693.76M91.58M
2022-01-10-0.39-0.4883.45M91.76M
2021-10-07-0.43-0.4573.29M72.88M
2021-07-08-0.39-0.3259.53M55.66M
2021-05-050.02-0.0759.23M—
2021-01-07-0.26-0.3338.44M41.74M
2020-10-14-0.41-0.4036.79M30.35M
2020-08-13-1.69-0.4035.89M—
2020-07-07-0.05—44.44M—
2019-11-30-0.53—29.65M—
2019-08-31-0.43—29.65M—
2019-05-31-0.46—28.76M—
2019-02-28-0.20—35.09M—
2018-11-30-3.92—21.04M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2025-04-08SINGH RAJEEVBuy175.00K——
2025-04-08SINGH RAJEEVBuy136.29K——
2025-04-08SINGH RAJEEVSell175.00K——
2025-04-08SINGH RAJEEVSell904.81K$4.203.80M
2025-04-08SINGH RAJEEVSell18.12K$4.5081.56K
2025-04-08SINGH RAJEEVSell12.50K$4.7058.75K
2025-04-08SINGH RAJEEVSell17.85K$17.50312.31K
2025-04-08SINGH RAJEEVSell120.60K$8.03968.42K
2025-04-08SINGH RAJEEVSell504.47K$9.604.84M
2025-04-08SINGH RAJEEVSell651.62K$7.034.58M
2025-04-08SINGH RAJEEVSell89.55K$53.384.78M
2025-04-08LEPORE DAWN GSell35.02K——
2025-04-08LEPORE DAWN GSell20.00K$9.60192.00K
2025-04-08LEPORE DAWN GSell8.60K$17.50150.50K
2025-04-08Kent CindySell1.36K$7.039.56K
2025-04-08Kent CindySell12.65K——
2025-04-08WADORS PATRICIA LSell20.00K$15.40308.00K
2025-04-08WADORS PATRICIA LSell35.02K——
2025-04-08WADORS PATRICIA LSell27.76K$7.03195.15K
2025-04-08Klein Peter SSell20.00K$13.65273.00K
2025-04-08Klein Peter SSell8.60K$17.50150.50K
2025-04-08Klein Peter SSell28.33K$7.03199.15K
2025-04-08Klein Peter SSell35.02K——
2025-04-08JORDAN JEFFREY DSell35.02K——
2025-04-08JORDAN JEFFREY DSell1.62M$7.0311.38M
2025-04-08BRODSKY JEFFREY SSell46.81K$7.03329.07K
2025-04-08BRODSKY JEFFREY SSell6.25K——
2025-04-08NABEL ELIZABETH GSell12.49K——
2025-04-08NABEL ELIZABETH GSell41.98K$7.03295.13K
2025-04-08Barnes Stephen H.Buy67.50K——
2025-04-08Barnes Stephen H.Buy56.46K——
2025-04-08Barnes Stephen H.Sell67.50K——
2025-04-08Barnes Stephen H.Sell8.50K$4.7039.95K
2025-04-08Barnes Stephen H.Sell10.63K$17.50186.11K
2025-04-08Barnes Stephen H.Sell39.80K$53.382.12M
2025-04-08Barnes Stephen H.Sell56.28K$8.03451.93K
2025-04-08Barnes Stephen H.Sell306.87K$7.032.16M
2025-04-08Barnes Stephen H.Sell15.00K$4.2063.00K
2025-04-08Barnes Stephen H.Sell135.00K$9.601.30M
2025-04-08Eskew RichardBuy37.50K——
2025-04-08Eskew RichardBuy27.26K——
2025-04-08Eskew RichardSell8.78K$17.50153.60K
2025-04-08Eskew RichardSell20.00K$4.7094.00K
2025-04-08Eskew RichardSell12.44K$53.38663.94K
2025-04-08Eskew RichardSell20.00K$6.27125.40K
2025-04-08Eskew RichardSell66.19K$7.03465.32K
2025-04-08Eskew RichardSell12.00K$9.60115.20K
2025-04-08Eskew RichardSell10.25K$4.2043.05K
2025-04-08Eskew RichardSell20.00K$6.55131.00K
2025-04-08Eskew RichardSell37.50K——
2025-04-08Cavanaugh Robert NBuy56.46K——
2025-04-08Cavanaugh Robert NBuy55.00K——
2025-04-08Cavanaugh Robert NSell55.00K——
2025-04-08Cavanaugh Robert NSell51.92K$8.03416.96K
2025-04-08Cavanaugh Robert NSell48.95K$53.382.61M
2025-04-08Cavanaugh Robert NSell8.50K$4.7039.95K
2025-04-08Cavanaugh Robert NSell15.00K$4.2063.00K
2025-04-08Cavanaugh Robert NSell222.22K$7.031.56M
2025-04-08Cavanaugh Robert NSell200.00K$9.601.92M
2025-04-08Cavanaugh Robert NSell13.97K$17.50244.49K
2025-04-08HILTON MICHAEL WSell10.23K$17.50179.09K
2025-04-08HILTON MICHAEL WSell195.04K$7.031.37M
2025-04-08HILTON MICHAEL WSell20.00K$4.2084.00K
2025-04-08HILTON MICHAEL WSell11.17K$8.0389.66K
2025-04-08HILTON MICHAEL WSell8.50K$4.7039.95K
2025-04-08HILTON MICHAEL WSell145.00K$9.601.39M
2025-04-08HILTON MICHAEL WSell27.86K$53.381.49M
2025-04-08HILTON MICHAEL WSell12.49K——
2025-04-02Barnes Stephen H.Sell431$6.993.01K
2025-04-02Cavanaugh Robert NSell550$6.993.85K
2025-04-02SINGH RAJEEVSell922$6.996.45K
2025-04-02Eskew RichardSell378$6.992.64K
2025-04-01Barnes Stephen H.Buy1.57K——
2025-04-01Barnes Stephen H.Sell1.57K——
2025-04-01Cavanaugh Robert NBuy1.57K——
2025-04-01Cavanaugh Robert NSell1.57K——
2025-04-01SINGH RAJEEVBuy3.79K——
2025-04-01SINGH RAJEEVSell3.79K——
2025-04-01Eskew RichardBuy389——
2025-04-01Eskew RichardBuy757——
2025-04-01Eskew RichardSell757——
2025-04-01Eskew RichardSell389——
2025-03-25Cavanaugh Robert NBuy2.50K$3.167.90K
2025-03-25Eskew RichardBuy639$3.162.02K
2025-03-25Barnes Stephen H.Buy1.70K$3.165.38K
2025-03-18SINGH RAJEEVSell289$6.992.02K
2025-03-18Barnes Stephen H.Sell142$6.99992
2025-03-18Cavanaugh Robert NSell181$6.991.26K
2025-03-17SINGH RAJEEVBuy933——
2025-03-17SINGH RAJEEVSell933——
2025-03-17Barnes Stephen H.Buy415——
2025-03-17Barnes Stephen H.Sell415——
2025-03-17Cavanaugh Robert NBuy510——
2025-03-17Cavanaugh Robert NSell510——
2025-03-11Cavanaugh Robert NSell249$6.961.73K
2025-03-11Barnes Stephen H.Sell254$6.961.77K
2025-03-11SINGH RAJEEVSell490$6.963.41K
2025-03-10Cavanaugh Robert NBuy710——
2025-03-10Cavanaugh Robert NSell710——
2025-03-10Barnes Stephen H.Buy770——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener

Accolade (ACCD) Stock Price & Analysis

ACCD$7.020.00 0.00%

$575.59M

Market Cap

-5.28

P/E

19.50

Forward P/E

57

Score

AI Analysis

Snapshot

Loading market score…

Price History

Financial Summary

Accolade, Inc. (ACCD) trades at $7.02, with a market cap of $575.59M and a trailing P/E of -5.28. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2018201920202021202220232024
$76.83M$94.81M$132.51M$170.36M$310.02M$363.14M$414.29M

About

Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal support. This assistance comes from a dedicated team of health assistants and clinical professionals, including registered nurses, physician medical directors, and specialists in behavioral health. Furthermore, Accolade extends its services to include valuable second opinion consultations and crucial decision-making support for healthcare matters. The company primarily serves employers who aim to furnish their employees and their families with a unified, easily accessible resource for all their health, medical care, and benefits-related inquiries. Established in 2007, Accolade, Inc. maintains its corporate headquarters in Plymouth Meeting, Pennsylvania.